Cytosorbents (CTSO) Raw Materials (2023 - 2026)

Cytosorbents (CTSO) has reported Raw Materials for 4 consecutive years, with $658000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Raw Materials rose 34.01% year-over-year to $658000.0; the trailing twelve-month figure through Jun 2026 stood at $658000.0 (up 34.01% YoY), and the FY2025 full-year result was $751000.0, up 31.75% from the prior year.
• Raw Materials improved to $658000.0 in Q2 2026 per CTSO's latest filing, from $552000.0 in the prior quarter.
• Across five years, Raw Materials topped out at $751000.0 in Q4 2025 and bottomed at $491000.0 in Q2 2025.
• Historically, Raw Materials has averaged $602450.8 across 4 years, with a median of $567500.0 in 2024.
• The sharpest annual moves came in 2024 and 2026: Raw Materials slipped 16.89% in 2024, then surged 34.01% in 2026.
• Over 4 years, Raw Materials stood at $685801.0 in 2023, then retreated by 16.89% to $570000.0 in 2024, then surged by 31.75% to $751000.0 in 2025, then retreated by 12.38% to $658000.0 in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $658000.0, $552000.0, and $751000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.